Cellcolabs, specializing in industrial production of mesenchymal stromal cells (MSC) has raised 64 MSEK in an oversubscribed round. Both current owners Takura and Norrsken Foundation participated, and alongside them a number of well-known Swedish individual investors.
Cellcolabs has just moved to its brand-new production facility at Retzius väg 8 in Solna. The money will be used to scale production with the goal of lowering prices and making high quality MSC more broadly available for research and treatments.